Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: A single-institution experience

Cancer Investigation

Volumn 20, Issue 1, 2002, Pages 3-10

  Abushullaih, Samer ^a   Saad, Everardo D ^a   Munsell, Mark ^a   Hoff, Paulo M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Capecitabine; Chemotherapy side effects; Colorectal cancer; Hand foot syndrome

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE COURSE; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DYSESTHESIA; EDEMA; ERYTHEMA; FEMALE; HAND FOOT SYNDROME; HUMAN; INCIDENCE; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SCORING SYSTEM; SKIN BIOPSY; STATISTICAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; FEMALE; HUMANS; INCIDENCE; KERATODERMA, PALMOPLANTAR; MALE; MIDDLE AGED; PRODRUGS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036174497     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120000360     Document Type: Article

References (30)

1. Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia
2. Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome
3. Chemotherapy-induced acral erythema
4. A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin
5. Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: A phase I study
6. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere
7. Hand-foot syndrome following prolonged infusion of high doses of vinorelbine
8. Capecitabine
9. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
10. Preliminary studies of a novel oral fluoropyrimidine carbamate: Capecitabine
11. Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer
12. A phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors
13. A randomized phase II study of Xeloda™ (capecitabine) in patients with advanced colorectal cancer
14. A phase III trial (SO14796) of Xeloda™ (capecitabine) in previously untreated advanced/metastatic colorectal cancer
15. A phase III trial of Xeloda™ (capecitabine) in previously untreated advanced/metastatic colorectal cancer
16. Toxicity of fluorouracil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors
17. Cancer chemotherapy and skin changes
18. Anthracycline-induced toxicity affecting palmar and plantar skin
19. Palmar-plantar skin changes and cytarabine
20. Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy
21. The role of dihydropyrimidine dehydrogenase (DPD) modulation in 5-FU pharmacology
22. UFT and leucovorin: A review of its clinical development and therapeutic potential in the oral treatment of cancer
23. Pyridoxine for the palmar-plantar erythrodysesthesia syndrome
24. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion
25. Vitamin B6 and skin lesions in rats
26. Pyridoxine (B6) and amelioration of hand/foot syndrome
27. Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (stealth) liposomes: A randomized, double-blind clinical trial using a canine model